We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Healthcare Reconciliation Bill in House Preserves Biosimilar, Drug Discount Provisions
Healthcare Reconciliation Bill in House Preserves Biosimilar, Drug Discount Provisions
March 19, 2010
Drugmakers will have to provide a 50 percent discount starting next year for Medicare Part D beneficiaries whose pharmaceutical costs fall into the “doughnut hole” coverage gap, under the healthcare reconciliation bill.